Short answer

Incorporate iterative user feedback and affordance theory into the design process to create intuitive and effective data visualization tools, particularly for critical applications like drug safety surveillance.

Field
User-Centred Design
Source
JMIR Medical Informatics (2026)
Method
Design Science Research with iterative design and evaluation cycles.
Sample
10 participants (4 professional end users, 6 non-professional end users)
Evidence
Strong effect

Iterative user involvement and affordance theory can guide the development of drug safety surveillance dashboards, leading to improved usability and decision-making. This user-centred design research insight is drawn from a 2026 study published in JMIR Medical Informatics. Using Design science research with iterative design and evaluation cycles. with 10 participants (4 professional end users, 6 non-professional end users), researchers explored how this design variable affects real-world outcomes. The key design takeaway: Incorporate iterative user feedback and affordance theory into the design process to create intuitive and effective data visualization tools, particularly for critical applications like drug safety surveillance.

Study
User-Centred DesignNew This WeekStrong effect

Eight Design Principles for Effective Drug Safety Dashboards

Iterative user involvement and affordance theory can guide the development of drug safety surveillance dashboards, leading to improved usability and decision-making.

JMIR Medical Informatics · 2026

01

Key Findings

  • 01Developed 8 design principles (DPs) for drug safety dashboards.
  • 02DPs address immediate use, pattern identification, trend tracking, user-controlled views, data granularity, visual attention guidance, public value, and decision-making support.
  • 03A high-fidelity prototype achieved an 84% usability score via heuristic evaluation.
02

Application

Design takeaway

Incorporate iterative user feedback and affordance theory into the design process to create intuitive and effective data visualization tools, particularly for critical applications like drug safety surveillance.

How to apply

When designing any data-intensive dashboard, engage end-users early and often, and consider how the interface's affordances can guide users towards meaningful insights and actions.

Project actions

  • 01Clearly define your target user groups and their specific needs.
  • 02Use iterative prototyping and testing to refine your design based on user feedback.
03

Method & Evidence

AimTo develop and iteratively refine design principles for drug safety surveillance dashboards through active end-user involvement, utilizing affordance theory.
MethodDesign Science Research with iterative design and evaluation cycles.
ProcedureConducted co-design workshops, usability testing with think-aloud protocols, and heuristic evaluations involving both professional and non-professional end users across three iterative design cycles. Affordance theory was used to refine design principles based on user feedback and prototype interactions.
Sample10 participants (4 professional end users, 6 non-professional end users)
ContextDrug safety surveillance and healthcare informatics.

Variables

IV["Design principles (e.g., immediate use, pattern identification, user control)","Affordance theory application"]
DV["Dashboard usability score","User interaction patterns","Effectiveness in guiding decision-making"]
CV["User expertise level (professional vs. non-professional)","Type of data being visualized (drug safety)","Iterative design cycles"]
04

Strengths & Limitations

Strengths

  • +Employs a rigorous Design Science Research methodology.
  • +Integrates user-centered design with theoretical frameworks (affordance theory).

Limitations

The number of participants may be small, and the specific context of drug safety might limit generalizability to other domains.

Reliability & validity

The iterative nature of the design and evaluation process, along with the use of multiple evaluation methods (co-design, think-aloud, heuristic evaluation), enhances the reliability and validity of the derived design principles. However, the small sample size may limit generalizability.

Think critically

How might the 'bootstrap problem' for new users of drug safety dashboards be addressed in other complex data visualization contexts?

05

Design Principles

"Design for immediate use, pattern identification, trend tracking, user-controlled views, customizable data granularity, guided visual attention, public value, and stakeholder-specific decision support."

Designing effective dashboards for complex data, such as drug safety surveillance, requires a deep understanding of user needs and how they interact with information. This research provides a framework for creating such tools that are not only functional but also intuitive and actionable for diverse user groups.

06

What This Means for Your Design

To make a good drug safety dashboard, designers should ask users what they need and how they use it, then use design ideas (like how buttons look and work) to make it easy to understand and use.

How to use in your project

  • 1.Reference the design principles identified in this study as a foundation for your own dashboard design.
  • 2.Justify your design choices by relating them back to these principles and user needs.
07

Add to My Project

08

Quick Cite

Paragraph starter

This design project draws upon established principles for effective dashboard design, particularly those identified in research on drug safety surveillance. The developed design principles, such as designing for immediate use, enabling pattern identification, and supporting user-controlled views, provide a robust framework for creating intuitive and actionable interfaces. By incorporating these principles and engaging in iterative user testing, the aim is to develop a solution that enhances user understanding and decision-making capabilities.

09

Source

JMIR Medical Informatics

Design Principles for Interactive Dashboards in Drug Safety Surveillance: Design Science Research

journal · 2026

View source

Questions About This Research

What does the research say about eight design principles for effective drug safety dashboards?
Incorporate iterative user feedback and affordance theory into the design process to create intuitive and effective data visualization tools, particularly for critical applications like drug safety surveillance. Evidence: JMIR Medical Informatics (2026).
Why does "Eight Design Principles for Effective Drug Safety Dashboards" matter for design?
Designing effective dashboards for complex data, such as drug safety surveillance, requires a deep understanding of user needs and how they interact with information. This research provides a framework for creating such tools that are not only functional but also intuitive and actionable for diverse user groups.
How can designers apply this research?
Incorporate iterative user feedback and affordance theory into the design process to create intuitive and effective data visualization tools, particularly for critical applications like drug safety surveillance.
What were the main findings?
Developed 8 design principles (DPs) for drug safety dashboards.. DPs address immediate use, pattern identification, trend tracking, user-controlled views, data granularity, visual attention guidance, public value, and decision-making support.. A high-fidelity prototype achieved an 84% usability score via heuristic evaluation.
What research method was used?
Design Science Research with iterative design and evaluation cycles. with 10 participants (4 professional end users, 6 non-professional end users).
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2026 journal from JMIR Medical Informatics.
What should I do differently in my next project?
When designing any data-intensive dashboard, engage end-users early and often, and consider how the interface's affordances can guide users towards meaningful insights and actions.
What are the limitations?
The study involved a small sample size of end users, and the findings may be specific to the context of drug safety surveillance.